{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:31:09Z","timestamp":1792704669999,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":1418,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1186\/s13613-022-01021-9","type":"journal-article","created":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T23:23:34Z","timestamp":1653866614000},"page":"47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Timing of vasoactive agents and corticosteroid initiation in septic shock"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3401-9960","authenticated-orcid":false,"given":"Mahmoud A.","family":"Ammar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdalla A.","family":"Ammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Wieruszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany D.","family":"Bissell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah","family":"T. Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish K.","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen L.","family":"Sacha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1186\/s13613-022-01021-9_bb0010","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1164\/rccm.201504-0781OC","article-title":"Assessment of global incidence and mortality of hospital-treated sepsis current estimates and limitations","volume":"193","author":"International Forum of Acute Care T","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1186\/s13613-022-01021-9_bb0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/jama.2014.5804","article-title":"Hospital deaths in patients with sepsis from 2 independent cohorts","volume":"312","author":"Liu","year":"2014","journal-title":"JAMA"},{"issue":"11","key":"10.1186\/s13613-022-01021-9_bb0020","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1186\/s13613-022-01021-9_bb0025","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/SHK.0000000000000473","article-title":"The Endothelium in Sepsis","volume":"45","author":"Ince","year":"2016","journal-title":"Shock"},{"issue":"4","key":"10.1186\/s13613-022-01021-9_bb0030","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/1060028019887160","article-title":"Pathophysiology of volume administration in septic shock and the role of the clinical pharmacist","volume":"54","author":"Bissell","year":"2020","journal-title":"Ann Pharmacother"},{"key":"10.1186\/s13613-022-01021-9_bb0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13613-014-0025-9","article-title":"Duration of hemodynamic effects of crystalloids in patients with circulatory shock after initial resuscitation","volume":"4","author":"Nunes","year":"2014","journal-title":"Ann Intensive Care"},{"issue":"5","key":"10.1186\/s13613-022-01021-9_bb0040","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/CCM.0000000000001517","article-title":"Pharmacodynamic analysis of a fluid challenge","volume":"44","author":"Aya","year":"2016","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1186\/s13613-022-01021-9_bb0045","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00134-015-3898-7","article-title":"Effects of fluid administration on arterial load in septic shock patients","volume":"41","author":"Monge Garcia","year":"2015","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1186\/s13613-022-01021-9_bb0050","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1186\/s13613-022-01021-9_bb0055","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.clinthera.2016.12.003","article-title":"Effect of immediate administration of antibiotics in patients with sepsis in tertiary care: a systematic review and meta-analysis","volume":"39","author":"Johnston","year":"2017","journal-title":"Clin Ther"},{"issue":"23","key":"10.1186\/s13613-022-01021-9_bb0060","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","article-title":"Time to treatment and mortality during mandated emergency care for sepsis","volume":"376","author":"Seymour","year":"2017","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1186\/s13613-022-01021-9_bb0065","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1164\/rccm.201609-1848OC","article-title":"The timing of early antibiotics and hospital mortality in sepsis","volume":"196","author":"Liu","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1186\/s13613-022-01021-9_bb0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40360-016-0063-z","article-title":"Temporal trends in the utilization of vasopressors in intensive care units: an epidemiologic study","volume":"17","author":"Thongprayoon","year":"2016","journal-title":"BMC Pharmacol Toxicol"},{"issue":"3","key":"10.1186\/s13613-022-01021-9_bb0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/phar.2220","article-title":"Vasoactive agent use in septic shock: beyond first-line recommendations","volume":"39","author":"Sacha","year":"2019","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1186\/s13613-022-01021-9_bb0080","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/emj.2008.070912","article-title":"Variability in management of early severe sepsis","volume":"27","author":"Reade","year":"2010","journal-title":"Emerg Med J"},{"issue":"6","key":"10.1186\/s13613-022-01021-9_bb0085","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.201101-0037OC","article-title":"Prompting physicians to address a daily checklist and process of care and clinical outcomes: a single-site study","volume":"184","author":"Weiss","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1186\/s13613-022-01021-9_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129305","article-title":"Vasopressors for the treatment of septic shock: systematic review and meta-analysis","volume":"10","author":"Avni","year":"2015","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1186\/s13613-022-01021-9_bb0095","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"issue":"9","key":"10.1186\/s13613-022-01021-9_bb0100","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1186\/s13613-022-01021-9_bb0105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jcrc.2020.02.014","article-title":"Relationship between norepinephrine dose, tachycardia and outcome in septic shock: a multicentre evaluation","volume":"57","author":"Domizi","year":"2020","journal-title":"J Crit Care"},{"issue":"4","key":"10.1186\/s13613-022-01021-9_bb0110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/SHK.0000000000000426","article-title":"Norepinephrine: not too much too long","volume":"44","author":"Martin","year":"2015","journal-title":"Shock"},{"issue":"1","key":"10.1186\/s13613-022-01021-9_bb0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcrc.2013.09.004","article-title":"Does high-dose vasopressor therapy in medical intensive care patients indicate what we already suspect?","volume":"29","author":"Sviri","year":"2014","journal-title":"J Crit Care"},{"issue":"3","key":"10.1186\/s13613-022-01021-9_bb0120","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1378\/chest.12-1106","article-title":"Survival after shock requiring high-dose vasopressor therapy","volume":"143","author":"Brown","year":"2013","journal-title":"Chest"},{"issue":"1","key":"10.1186\/s13613-022-01021-9_bb0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13613-017-0261-x","article-title":"Outcome of patients with septic shock and high-dose vasopressor therapy","volume":"7","author":"Auchet","year":"2017","journal-title":"Ann Intensive Care"},{"issue":"12","key":"10.1186\/s13613-022-01021-9_bb0130","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1007\/s00134-019-05770-3","article-title":"Less is more: catecholamine-sparing strategies in septic shock","volume":"45","author":"Venkatesh","year":"2019","journal-title":"Intensive Care Med"},{"key":"10.1186\/s13613-022-01021-9_bb0135","doi-asserted-by":"crossref","DOI":"10.1007\/s00134-022-06652-x","article-title":"Dose of norepinephrine: the devil is in the details","author":"Leone","year":"2022","journal-title":"Intensive Care Med"},{"issue":"10","key":"10.1186\/s13613-022-01021-9_bb0140","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/CCM.0000000000004476","article-title":"Evaluation of vasopressor exposure and mortality in patients with septic shock","volume":"48","author":"Roberts","year":"2020","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1186\/s13613-022-01021-9_bb0145","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1097\/CCM.0000000000005363","article-title":"vasopressor initiation within 1 hour of fluid loading is associated with increased mortality in septic shock patients: analysis of national registry data","volume":"50","author":"Korean sepsis alliance I","year":"2022","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1186\/s13613-022-01021-9_bb0150","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13613-018-0448-9","article-title":"Mean arterial pressure and mortality in patients with distributive shock: a retrospective analysis of the MIMIC-III database","volume":"8","author":"Vincent","year":"2018","journal-title":"Ann Intensive Care"},{"issue":"6","key":"10.1186\/s13613-022-01021-9_bb0155","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00134-018-5218-5","article-title":"The relationship between ICU hypotension and in-hospital mortality and morbidity in septic patients","volume":"44","author":"Maheshwari","year":"2018","journal-title":"Intensive Care Med"},{"key":"10.1186\/s13613-022-01021-9_bb0160","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jcrc.2018.10.032","article-title":"Importance of diastolic arterial pressure in septic shock: PRO","volume":"51","author":"Hamzaoui","year":"2019","journal-title":"J Crit Care"},{"issue":"1","key":"10.1186\/s13613-022-01021-9_bb0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13613-020-00658-8","article-title":"Diastolic shock index and clinical outcomes in patients with septic shock","volume":"10","author":"Ospina-Tascon","year":"2020","journal-title":"Ann Intensive Care"},{"key":"10.1186\/s13613-022-01021-9_bb0170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jcrc.2019.11.004","article-title":"Delayed vasopressor initiation is associated with increased mortality in patients with septic shock","volume":"55","author":"Colon Hidalgo","year":"2020","journal-title":"J Crit Care"},{"issue":"5","key":"10.1186\/s13613-022-01021-9_bb0175","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1186\/s13054-014-0532-y","article-title":"Early versus delayed administration of norepinephrine in patients with septic shock","volume":"18","author":"Bai","year":"2014","journal-title":"Crit Care"},{"issue":"6","key":"10.1186\/s13613-022-01021-9_bb0180","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00134-018-5085-0","article-title":"The Surviving Sepsis Campaign Bundle: 2018 update","volume":"44","author":"Levy","year":"2018","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1186\/s13613-022-01021-9_bb0185","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00134-007-0862-1","article-title":"Liberal vs. conservative vasopressor use to maintain mean arterial blood pressure during resuscitation of septic shock: an observational study","volume":"34","author":"Subramanian","year":"2008","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1186\/s13613-022-01021-9_bb0190","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1164\/rccm.201806-1034OC","article-title":"Early use of norepinephrine in septic shock resuscitation (CENSER). a randomized trial","volume":"199","author":"Permpikul","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1186\/s13613-022-01021-9_bb0195","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1186\/s13613-022-01021-9_bb0200","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/phar.2105","article-title":"Prospective open-label trial of early concomitant vasopressin and norepinephrine therapy versus initial norepinephrine monotherapy in septic shock","volume":"38","author":"Hammond","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1186\/s13613-022-01021-9_bb0205","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the vanish randomized clinical trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"10.1186\/s13613-022-01021-9_bb0210","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13613-018-0379-5","article-title":"Predictors of response to fixed-dose vasopressin in adult patients with septic shock","volume":"8","author":"Sacha","year":"2018","journal-title":"Ann Intensive Care"},{"issue":"4","key":"10.1186\/s13613-022-01021-9_bb0215","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/CCM.0000000000005317","article-title":"Association of catecholamine dose, lactate, and shock duration at vasopressin initiation with mortality in patients with septic shock","volume":"50","author":"Sacha","year":"2022","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1186\/s13613-022-01021-9_bb0220","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1164\/rccm.202002-0339OC","article-title":"Norepinephrine dysregulates the immune response and compromises host defense during sepsis","volume":"202","author":"Stolk","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1186\/s13613-022-01021-9_bb0225","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13054-018-1995-z","article-title":"Angiotensin in critical care","volume":"22","author":"Hall","year":"2018","journal-title":"Crit Care"},{"key":"10.1186\/s13613-022-01021-9_bb0230","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jcrc.2020.12.020","article-title":"Challenges and importance of formulae equating catecholamine and non-catecholamine vasoconstrictor dosages","volume":"62","author":"Wieruszewski","year":"2021","journal-title":"J Crit Care"},{"issue":"5","key":"10.1186\/s13613-022-01021-9_bb0235","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1186\/s13613-022-01021-9_bb0240","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.chest.2020.08.2074","article-title":"Angiotensin II infusion for shock: a multicenter study of postmarketing use","volume":"159","author":"Wieruszewski","year":"2021","journal-title":"Chest"},{"issue":"1","key":"10.1186\/s13613-022-01021-9_bb0245","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/0885066620972943","article-title":"A multicenter observational cohort study of angiotensin II in shock","volume":"37","author":"Smith","year":"2022","journal-title":"J Intensive Care Med"},{"issue":"3","key":"10.1186\/s13613-022-01021-9_bb0250","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.00036.2005","article-title":"physiology of local renin-angiotensin systems","volume":"86","author":"Paul","year":"2006","journal-title":"Physiol Rev"},{"issue":"9","key":"10.1186\/s13613-022-01021-9_bb0255","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","article-title":"Renin and survival in patients given angiotensin ii for catecholamine-resistant vasodilatory shock. a clinical trial","volume":"202","author":"Bellomo","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1186\/s13613-022-01021-9_bb0260","first-page":"411","article-title":"Vasopressor use in cardiogenic shock","volume":"26","author":"Levy","year":"2020","journal-title":"Curr Opin Crit Care"},{"key":"10.1186\/s13613-022-01021-9_bb0265","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcrc.2019.05.024","article-title":"Optimal norepinephrine-equivalent dose to initiate epinephrine in patients with septic shock","volume":"53","author":"Ammar","year":"2019","journal-title":"J Crit Care"},{"issue":"11","key":"10.1186\/s13613-022-01021-9_bb0270","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00134-019-05801-z","article-title":"Vasopressor therapy in critically ill patients with shock","volume":"45","author":"Russell","year":"2019","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1186\/s13613-022-01021-9_bb0275","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/SHK.0000000000001022","article-title":"Vasopressor cumulative dose requirement and risk of early death during septic shock: an analysis from the EPISS cohort","volume":"49","author":"Group Es","year":"2018","journal-title":"Shock"},{"issue":"1","key":"10.1186\/s13613-022-01021-9_bb0280","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1186\/s13054-021-03813-0","article-title":"Equilibrating SSC guidelines with individualized care","volume":"25","author":"Vincent","year":"2021","journal-title":"Crit Care"},{"issue":"1","key":"10.1186\/s13613-022-01021-9_bb0285","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/phar.2346","article-title":"Vasopressin plasma concentrations are not associated with hemodynamic response to exogenous vasopressin for septic shock","volume":"40","author":"Yerke","year":"2020","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1186\/s13613-022-01021-9_bb0290","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/cc8224","article-title":"Bench-to-bedside review: vasopressin in the management of septic shock","volume":"15","author":"Russell","year":"2011","journal-title":"Crit Care"},{"issue":"2","key":"10.1186\/s13613-022-01021-9_bb0295","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/CCM.0000000000003544","article-title":"Renin as a marker of tissue-perfusion and prognosis in critically Ill patients","volume":"47","author":"Gleeson","year":"2019","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1186\/s13613-022-01021-9_bb0300","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/CCM.0000000000005143","article-title":"Renin kinetics are superior to lactate kinetics for predicting in-hospital mortality in hypotensive critically Ill patients","volume":"50","author":"Jeyaraju","year":"2022","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1186\/s13613-022-01021-9_bb0305","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00003246-200105000-00041","article-title":"Effect of corticosteroids on nuclear factor-kappaB activation and hemodynamics in late septic shock","volume":"29","author":"van Leeuwen","year":"2001","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1186\/s13613-022-01021-9_bb0310","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0008-6363(98)00230-2","article-title":"The role of corticosteriods in the regulation of vascular tone","volume":"41","author":"Ullian","year":"1999","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1186\/s13613-022-01021-9_bb0315","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00003246-200301000-00022","article-title":"Adrenal insufficiency during septic shock","volume":"31","author":"Marik","year":"2003","journal-title":"Crit Care Med"},{"issue":"9","key":"10.1186\/s13613-022-01021-9_bb0320","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/CCM.0000000000003262","article-title":"Corticosteroids in sepsis: an updated systematic review and meta-analysis","volume":"46","author":"Rochwerg","year":"2018","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1186\/s13613-022-01021-9_bb0325","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"issue":"2","key":"10.1186\/s13613-022-01021-9_bb0330","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock","volume":"358","author":"Sprung","year":"2008","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1186\/s13613-022-01021-9_bb0335","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1186\/s13613-022-01021-9_bb0340","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1186\/s13613-022-01021-9_bb0345","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/0018578719829416","article-title":"Corticosteroids for septic shock: another chapter in the saga","volume":"55","author":"Yerke","year":"2020","journal-title":"Hosp Pharm"},{"issue":"7","key":"10.1186\/s13613-022-01021-9_bb0350","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00134-018-5197-6","article-title":"Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis","volume":"44","author":"Rygard","year":"2018","journal-title":"Intensive Care Med"},{"issue":"12","key":"10.1186\/s13613-022-01021-9_bb0355","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00134-017-4919-5","article-title":"Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): society of critical care medicine (SCCM) and European society of intensive care medicine (ESICM) 2017","volume":"43","author":"Annane","year":"2017","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1186\/s13613-022-01021-9_bb0360","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/SHK.0000000000001651","article-title":"Evaluation of the initiation timing of hydrocortisone in adult patients with septic shock","volume":"55","author":"Sacha","year":"2021","journal-title":"Shock"},{"issue":"3","key":"10.1186\/s13613-022-01021-9_bb0365","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/10600280211021103","article-title":"Comparison of early versus late initiation of hydrocortisone in patients with septic shock in the ICU setting","volume":"56","author":"Ragoonanan","year":"2022","journal-title":"Ann Pharmacother"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-022-01021-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13613-022-01021-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025006181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025006181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-022-01021-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:33:08Z","timestamp":1776670388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582025006181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"alternative-id":["S2110582025006181"],"URL":"https:\/\/doi.org\/10.1186\/s13613-022-01021-9","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Timing of vasoactive agents and corticosteroid initiation in septic shock","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s13613-022-01021-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The Author(s) 2022. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}],"article-number":"47"}}